Scope of the Study
Microcarrier is basically used to culture larger quantities of adherent cells in a fraction of the space of traditional static culture systems. They combine the advantages of traditional flask technology with those of suspension cultures. Currently, large scale expansion of cells using microcarriers may be achieved in bioreactors in a controlled environment, which allows precise control and monitoring of multiple parameters such as pH, dissolved oxygen, and temperature. Rising use of the microcarrier in cell therapy is projected the growth of the market over the forecast period.
The market study is being classified by Type (Cationic Microcarriers, Collagen-coated Microcarriers, Protein-coated Microcarriers, Untreated Microcarriers and Others), by Application (Vaccine Manufacturing, Cell Therapy, Biologics Manufacturing and Others) and major geographies with country level break-up.
Thermo Fisher Scientific (United States), GE Healthcare (United States), Merck KGaA (Germany), Corning Incorporated (United States), Danaher Corporation (United States), Sartorius AG (Germany), Lonza (Switzerland), Becton, Dickinson, and Company (United States), Eppendorf AG (Germany) and HiMedia Laboratories (India) are some of the key players profiled in the study.
The Players having a strong hold in the market are Thermo Fisher Scientific, GE Healthcare, Merck KGaA, and Corning Incorporated. Research Analyst at AMA predicts that United States and European Players will contribute to the maximum growth of Global Microcarrier market throughout the predicted period.
AdvanceMarketAnalytics has segmented the market of Global Microcarrier market by Type, Application and Region.
On the basis of geography, the market of Microcarrier has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- Increasing Demand for Cell-Based Vaccines and Therapeutics
- Rapid Growth of Biologics and Biosimilar Industry
- Increasing Significance of Microcarriers in Cell therapy
- High Cost of Cell Biology Research
- limitations in the production of high-density cell culture
- Increasing Research and Development and Availability of Funding for Cell Therapy Research
On 17, April 2018, Thermo Fisher Scientific has announced the bioprocessing technologies to be featured at their International Pharmaceutical Expo exhibit in the Jacob K. Javits Convention Center.
Key Target AudienceMicrocarrier Manufacturers, Manufacturers of culture equipment and media, Manufacturers of microcarrier beads, Potential Technology Investors, Regulatory & Government Bodies, Downstream Vendors and Other
Customization in the Report Available:The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase